VERU INC. cotiza a 2.41 USD y tiene una capitalización bursátil de $41M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS) in Florida and internationally. It provides FC2 female condom for the dual protection against unplanned pregnancy and th…
| Periodo | 2026-12 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.30 | $-0.13 | $-0.26 |
| Estimado | $-0.28 | $-0.32 | $-0.28 | $-0.47 |
| Sorpresa | — | +6.3% | +53.6% | +44.7% |
| Métrica | VERU | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -124.0% | -40.4% | -83.6% |
| ROA | -76.2% | -32.0% | -44.2% |
| Current Ratio | 2.43 | 2.84 | -0.41 |
| Debt / Equity | — | 0.28 | — |